Forty-four cases in the UK within the last five years.

Which compound should you recommend for supplementation?

New evidence that romosozumab may lead to excess cardiovascular complications.

Research presented at the virtual European Society of Human Genetics 2020 conference.

The definition used in current guidelines no longer relates to the population for whom osteoporosis drugs are recommended, experts say.

Korean meta-analysis compared around 128,000 breast cancer cases and controls.

Age and sex demographics and certain drugs are predictors.

Denosumab significantly decreased vertebral fracture risk, but nonvertebral fractures rose short-term.

Serum vitamin D concentration <10 ng/mL is a marker of severe LDD and LBP.

International trial involved almost 3000 patients.

20%-35% increase seen in the hip, humerus, and clinical vertebral fractures.

Results find no link between vitamin D alone and fracture prevention.

The study from Sweden finds a lower risk the year before TKR, increased risk the year after.

A cross-sectional cohort of >6,000 middle-aged and older Chinese participants.